127 related articles for article (PubMed ID: 15714432)
21. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Klastersky J; Paesmans M
Support Care Cancer; 2007 Feb; 15(2):137-41. PubMed ID: 16967301
[TBL] [Abstract][Full Text] [Related]
22. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
[TBL] [Abstract][Full Text] [Related]
23. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
Johnson JR
N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12037157
[No Abstract] [Full Text] [Related]
24. Pharmacoeconomic analysis of liposomal amphotericin B versus voriconazole for empirical treatment of febrile neutropenia.
Collins CD; Stuntebeck ER; DePestel DD; Stevenson JG
Clin Drug Investig; 2007; 27(4):233-41. PubMed ID: 17358095
[TBL] [Abstract][Full Text] [Related]
25. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
[TBL] [Abstract][Full Text] [Related]
27. Breakthrough Candida infections in patients receiving voriconazole.
Gerzenshtein L; Patel SM; Scarsi KK; Postelnick MJ; Flaherty JP
Ann Pharmacother; 2005; 39(7-8):1342-5. PubMed ID: 15914520
[TBL] [Abstract][Full Text] [Related]
28. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy.
Brugière O; Dauriat G; Mal H; Marrash-Chalha R; Fournier M; Groussard O; Besnard M; Lesèche G; Dupont B
Transplantation; 2005 Nov; 80(9):1361-2. PubMed ID: 16382553
[No Abstract] [Full Text] [Related]
30. Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report.
de Mol P; Meis JF
Neth J Med; 2009 Jan; 67(1):25-8. PubMed ID: 19155544
[TBL] [Abstract][Full Text] [Related]
31. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient.
Tong SY; Peleg AY; Yoong J; Handke R; Szer J; Slavin M
Transpl Infect Dis; 2007 Sep; 9(3):241-3. PubMed ID: 17605752
[TBL] [Abstract][Full Text] [Related]
32. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
Kaffarnik M; Utzolino S; Blaich A; Hopt UT
Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600
[TBL] [Abstract][Full Text] [Related]
33. Absidia corymbifera necrotizing cellulitis in an immunocompromised patient while on voriconazole treatment.
Pasticci MB; Terenzi A; Lapalorcia LM; Giovenale P; Pitzurra L; Costantini V; Lignani A; Gurdo G; Verzini F; Baldelli F
Ann Hematol; 2008 Aug; 87(8):687-9. PubMed ID: 18401584
[No Abstract] [Full Text] [Related]
34. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
Vehreschild JJ; Böhme A; Buchheidt D; Arenz D; Harnischmacher U; Heussel CP; Ullmann AJ; Mousset S; Hummel M; Frommolt P; Wassmer G; Drzisga I; Cornely OA
J Infect; 2007 Nov; 55(5):445-9. PubMed ID: 17822770
[TBL] [Abstract][Full Text] [Related]
35. Treatment of protothecosis with voriconazole.
Dalmau J; Pimentel CL; Alegre M; Sanchez F; Gurgui M; Roé E; Alomar A
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S122-3. PubMed ID: 17052532
[No Abstract] [Full Text] [Related]
36. Sinus zygomycosis in a patient receiving voriconazole prophylaxis.
Lionakis MS; Kontoyiannis DP
Br J Haematol; 2005 Apr; 129(1):2. PubMed ID: 15801950
[No Abstract] [Full Text] [Related]
37. Zygomycoses in patients with acute leukaemia.
Schalk E; Mohren M; Jentsch-Ullrich K; Dombrowski F; Franke A; Koenigsmann M
Ann Hematol; 2006 May; 85(5):327-32. PubMed ID: 16523312
[TBL] [Abstract][Full Text] [Related]
38. Acremonium vertebral osteomyelitis: molecular diagnosis and response to voriconazole.
Keynan Y; Sprecher H; Weber G
Clin Infect Dis; 2007 Jul; 45(1):e5-6. PubMed ID: 17554690
[TBL] [Abstract][Full Text] [Related]
39. Nasofacial phycomycosis: persistence pays.
Moore MH; Murphy D; James C
J Craniofac Surg; 2007 Mar; 18(2):448-50. PubMed ID: 17414301
[TBL] [Abstract][Full Text] [Related]
40. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
